INFI
Infinity Pharmaceuticals Inc
Price:  
0.04 
USD
Volume:  
22,131,812.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

INFI EV/EBITDA

-41150.0%
Upside

As of 2024-02-26, the EV/EBITDA ratio of Infinity Pharmaceuticals Inc (INFI) is 0.39. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INFI's latest enterprise value is -16.29 mil USD. INFI's TTM EBITDA according to its financial statements is -41.62 mil USD. Dividing these 2 quantities gives us the above INFI EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 11.1x - 14.3x 12.0x
Forward P/E multiples 16.2x - 18.3x 17.4x
Fair Price (20.23) - (17.75) (18.35)
Upside -45362.9% - -39803.1% -41150.0%
0.04 USD
Stock Price
(18.35) USD
Fair Price

INFI EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA